Driehaus Capital Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-568,470
| Closed | -$3.27M | – | 409 |
|
|
2024
Q2 | $3.27M | Buy |
568,470
+288,088
| +103% | +$1.66M | 0.03% | 276 |
|
|
2024
Q1 | $1.88M | Sell |
280,382
-63,338
| -18% | -$425K | 0.02% | 308 |
|
|
2023
Q4 | $2.22M | Hold |
343,720
| – | – | 0.03% | 293 |
|
|
2023
Q3 | $1.72M | Hold |
343,720
| – | – | 0.02% | 310 |
|
|
2023
Q2 | $2.42M | Hold |
343,720
| – | – | 0.03% | 294 |
|
|
2023
Q1 | $2.13M | Buy |
343,720
+13,669
| +4% | +$84.7K | 0.03% | 316 |
|
|
2022
Q4 | $2.11M | Hold |
330,051
| – | – | 0.03% | 291 |
|
|
2022
Q3 | $2.83M | Sell |
330,051
-52,889
| -14% | -$454K | 0.04% | 295 |
|
|
2022
Q2 | $5.21M | Buy |
382,940
+62,940
| +20% | +$856K | 0.08% | 270 |
|
|
2022
Q1 | $4.87M | Buy |
320,000
+230,000
| +256% | +$3.5M | 0.06% | 303 |
|
|
2021
Q4 | $2.06M | Buy |
+90,000
| New | +$2.06M | 0.02% | 302 |
|